The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
Open accessAbstract
BACKGROUND: Based on a hollow-fiber system model of tuberculosis, we hypothesize that microbiologic failure and acquired drug resistance are primarily driven by low drug concentrations that result from pharmacokinetic variability. METHODS: Clinical and pharmacokinetic data were prospectively collected from 142 tuberculosis patients in Western Cape, South Africa. Compartmental pharmacokinetic parameters of isoniazid, rifampin, and pyrazinamide were identified for each patient. Patients were then followed for up to 2 years. Classification and regression tree analysis was used to identify and rank clinical predictors of poor long-term outcome such as microbiologic failure or death, or relapse. RESULTS: Drug concentrations and pharmacokinetics varied widely between patients. Poor long-term outcomes were encountered in 35 (25%) patients. The 3 top predictors of poor long-term outcome, by rank of importance, were a pyrazinamide 24-hour area under the concentration-time curve (AUC) ≤ 363 mg·h/L, rifampin AUC ≤ 13 mg·h/L, and isoniazid AUC ≤ 52 mg·h/L. Poor outcomes were encountered in 32/78 patients with the AUC of at least 1 drug below the identified threshold vs 3/64 without (odds ratio = 14.14; 95% confidence interval, 4.08-49.08). Low rifampin and isoniazid peak and AUC concentrations preceded all cases of acquired drug resistance. CONCLUSIONS: Low drug AUCs are predictive of clinical outcomes in tuberculosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
The Fractal Geometry of Nature
Mandelbrot, B. B., & Wheeler, J. A. (1983) · American Journal of Physics · doi:10.1119/1.13295 · Cited by 21,832
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666
Classification and Regression Trees
(2022) · The R Book · doi:10.1002/9781119634461.ch20 · Cited by 499
Therapeutic Drug Monitoring in the Treatment of Tuberculosis
Peloquin, C. A. (2002) · Drugs · doi:10.2165/00003495-200262150-00001 · Cited by 446
Classification Trees With Unbiased Multiway Splits
Kim, H., & Loh, W.-Y. (2001) · Journal of the American Statistical Association · doi:10.1198/016214501753168271 · Cited by 391
Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin
Gumbo, T., Louie, A., Deziel, M. R., Liu, W., Parsons, L. M., Salfinger, M., & Drusano, G. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01533-06 · Cited by 345
Self-citationBactericidal and Sterilizing Activities of Antituberculosis Drugs during the First 14 Days
Jindani, A., Doré, C. J., & Mitchison, D. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1125oc · Cited by 321
Basic Mechanisms of Chemotherapy
Mitchison, D. A. (1979) · Chest · doi:10.1378/chest.76.6.771 · Cited by 301
Self-organization, complexity and chaos: The new biology for medicine
Coffey, D. S. (1998) · Nature Medicine · doi:10.1038/nm0898-882 · Cited by 287
Technical note: Some properties of splitting criteria
Breiman, L. (1996) · Machine Learning · doi:10.1007/bf00117831 · Cited by 270
Weiner, M., Benator, D., Burman, W., Peloquin, C. A., Khan, A., Vernon, A., Jones, B., Silva-Trigo, C., Zhao, Z., Hodge, T., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/429321 · Cited by 226
Schmalstieg, A. M., Srivastava, S., Belkaya, S., Deshpande, D., Meek, C., Leff, R., van Oers, N. S. C., & Gumbo, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05546-11 · Cited by 195
Self-citationRevised international definitions in tuberculosis control.
(2001) · PubMed · Cited by 187
Low Serum Antimycobacterial Drug Levels in Non-HIV-Infected Tuberculosis Patients
Kimerling, M. E., Phillips, P., Patterson, P., Hall, M., Robinson, C. A., & Dunlap, N. E. (1998) · Chest · doi:10.1378/chest.113.5.1178 · Cited by 170
Gumbo, T., Louie, A., Liu, W., Brown, D. L., Ambrose, P. G., Bhavnani, S. M., & Drusano, G. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-07 · Cited by 163
Self-citationChigutsa, E., Visser, M. E., Swart, R., Denti, P., Pushpakom, S. P., Egan, D., Holford, N. H. G., Smith, P. J., Maartens, G., Owen, A., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01833-10 · Cited by 155
Self-citationHeysell, S. K., Moore, J. L., Keller, S. J., & Houpt, E. R. (2010) · Emerging infectious diseases · doi:10.3201/eid1610.100374 · Cited by 154
Salfinger, M., & Heifets, L. B. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1002 · Cited by 146
Calver, A. D., Falmer, A. A., Murray, M. B., Strauss, O. J., Streicher, E. M., Hanekom, M., Liversage, T., Masibi, M., van Helden, P. D., Warren, R. M., et al. (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090968 · Cited by 143
Srivastava, S., Musuka, S., Sherman, C. M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651377 · Cited by 131
Andes, D. R., Ambrose, P. G., Hammel, J., Wart, S. A. V., Iyer, V., Reynolds, D. K., Buell, D. N., Kovanda, L. L., & Bhavnani, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01430-10 · Cited by 120
Pasipanodya, J. G., & Gumbo, T. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit167 · Cited by 119
Self-citationPopulation Pharmacokinetic Modeling of Pyrazinamide in Children and Adults with Tuberculosis
Zhu, M., Starke, J. R., Burman, W. J., et al. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.686.34067 · Cited by 74
Visser, M. E., Grewal, H. M. S., Swart, R., Dhansay, M. A., Walzl, G., Swanevelder, S. A., Lombard, C. J., & Maartens, G. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001784 · Cited by 64
Narita, M., Hisada, M., Thimmappa, B., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/318490 · Cited by 53
Hall, R. G., Swancutt, M. A., Meek, C. C., Leff, R. D., & Gumbo, T. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05623-11 · Cited by 42
Self-citationPopulation pharmacokinetics of rifampicin in Mexican patients with tuberculosis
Segovia, R. C. M., Ramírez, A. M. D., Cook, H. J., Aquino, M. M., Pérez, M. V., Brundage, R. C., & Moreno, S. R. (2012) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12016 · Cited by 30
Nonlinear dynamics in Clinical Pharmacology: the paradigm of cortisol secretion and suppression
Dokoumetzidis, A., Iliadis, A., & Macheras, P. E. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01600.x · Cited by 27
Pegylated Interferon Fractal Pharmacokinetics: Individualized Dosing for Hepatitis C Virus Infection
Jain, M. K., Pasipanodya, J. G., Alder, L., Lee, W. M., & Gumbo, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02208-12 · Cited by 18
Self-citationDrusano, G. L., Forrest, A. P., Yuen, G. J., Plaisance, K. I., & Leslie, J. L. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb01967.x · Cited by 15
Cited by
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citationEllington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update
Alsultan, A., & Peloquin, C. A. (2014) · Drugs · doi:10.1007/s40265-014-0222-8 · Cited by 444
Horsburgh, C. R., Barry, C. E., & Lange, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1413919 · Cited by 323
Lange, C., Abubakar, I., Alffenaar, J.-W. C., Bothamley, G., Caminero, J. A., Carvalho, A. C. C., Chang, K.-C., Codecasa, L., Correia, A., Crudu, V., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00188313 · Cited by 310
Metadata
- Authors
- Pasipanodya, J. G., McIlleron, H., Burger, A., Wash, P. A., Smith, P., & Gumbo, T.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-29
- Volume
- 208
- Issue
- 9
- Pages
- 1464-1473
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2107834145
- Cited by
- 444
- References
- 32
- FWCI
- 25.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.